RELIGARE ENT. Announces Quarterly Results (3QFY19); Net Profit Up 75.2%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

RELIGARE ENT. Announces Quarterly Results (3QFY19); Net Profit Up 75.2%
Fri, 22 Feb

RELIGARE ENT. has announced its results for the quarter ended December 2018. Here is a detailed performance review of the same:

RELIGARE ENT. Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-17*
3
Sep-18*
3
Dec-18*
QoQ ChangeYoY Change
Net SalesRs m78138-40.4%-90.1%
Other incomeRs m110111512.8%8575.0%
TurnoverRs m801151226.8%53.5%
ExpensesRs m3641071081.2%-70.3%
Gross profitRs m-286-94-100
DepreciationRs m522-10.9%-60.7%
InterestRs m127134116-13.7%-9.3%
Profit before taxRs m-417-128-103
TaxRs m0000.0%0.0%
Profit after taxRs m-417-128-103
Gross profit margin%-364.5-716.2-1,285.9
Effective tax rate%0.00.00.0
Net profit margin%-523.1-112.1-84.4
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 90.1% on a year-on-year (YoY) basis. The expenses were down by 70.3% YoY during the same period.
  • The company's operating profit declined by 64.9% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 1285.9% in 3QFY19 as against 364.5% in 3QFY18.
  • Depreciation charges declined by 60.7% and finance costs declined by 9.3% YoY, respectively.
  • Other income increased by 8575.0% YoY during the quarter.
  • Net profit for the quarter increased by 75.2% YoY. Net profit margins during the quarter increased from -523.1% in 3QFY18 to -84.4% in 3QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 40.4% on a quarter-on-quarter (QoQ) basis. The expenses were up by 1.2% QoQ during the same period.
  • The company's operating profit declined by 7.0% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 1285.9% in 3QFY19 as against 716.2% in 2QFY18.
  • Net profit for the quarter increased by 19.6% QoQ, while net profit margins increased from -111.3% in 2QFY18 to -84.4% in 3QFY19.

To see how RELIGARE ENT. has performed over the last eight quarters, please visit here.

RELIGARE ENT. Share Price Performance

Over the last one year, RELIGARE ENT. share price has moved up from Rs 54.4 to Rs 19.6, registering a Loss of Rs 34.8 or around 63.9%.

Overall, the S&P BSE SENSEX is up 6.0% over the year.

Current Valuations

At the current price of Rs 19.6, the price to book value (P/BV) ratio of RELIGARE ENT. stands at 0.2 times.

Equitymaster requests your view! Post a comment on "RELIGARE ENT. Announces Quarterly Results (3QFY19); Net Profit Up 75.2%". Click here!

  

Related Views on News

RELIGARE ENT. 2017-18 Annual Report Analysis (Annual Result Update)

Dec 21, 2018 | Updated on Dec 21, 2018

Here's an analysis of the annual report of RELIGARE ENT. for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of RELIGARE ENT.. Also includes updates on the valuation of RELIGARE ENT..

RELIGARE ENT. Announces Quarterly Results (2QFY19); Net Profit Up 57.9% (Quarterly Result Update)

Nov 29, 2018 | Updated on Nov 29, 2018

For the quarter ended September 2018, RELIGARE ENT. has posted a net profit of Rs 128 m (up 57.9% YoY). Sales on the other hand came in at Rs 13 m (down 50.7% YoY). Read on for a complete analysis of RELIGARE ENT.'s quarterly results.

RELIGARE ENT. Announces Quarterly Results (4QFY18); Net Profit Up 27.2% (Quarterly Result Update)

Jun 4, 2018 | Updated on Jun 4, 2018

For the quarter ended March 2018, RELIGARE ENT. has posted a net profit of Rs 643 m (up 27.2% YoY). Sales on the other hand came in at Rs 3 m (down 81.0% YoY). Read on for a complete analysis of RELIGARE ENT.'s quarterly results.

CreditAccess Grameen IPO: Should You Apply to this Interesting Microfinance Play? (IPO)

Aug 7, 2018

Should you apply to the IPO of CreditAccess Grameen Ltd?

HDFC AMC IPO: Do Valuations Leave Enough on Table for Investors? (IPO)

Jul 20, 2018

Should you subscribe to the IPO of HDFC AMC Ltd?

More Views on News

Most Popular

Use My Secret to Increase Your Trading Profits Today

Dec 10, 2019

What to do after every trade.

A Simple, 7-Step Checklist for Your Trading Success

Dec 4, 2019

What we can learn from one of the greatest traders to have ever lived.

Blue Chips Are Passe. Get into these Stocks for Outstanding Gains in 2020(Profit Hunter)

Dec 5, 2019

This corner of the market could provide more returns than blue chips in 2020.

Make the Most of the Smallcap Rebound with These Stocks(Profit Hunter)

Dec 3, 2019

Even amid a gloomy economic scenario, there are smallcaps that have grown earnings over last one and a half year and I believe these could be the strongest candidates for a smallcap rebound.

What Is the IPO Euphoria Signaling Us About the Markets?(The 5 Minute Wrapup)

Dec 2, 2019

2019 will be remembered as the year of great money-making IPOs...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

RELIGARE ENT. SHARE PRICE


Dec 13, 2019 (Close)

TRACK RELIGARE ENT.

  • Track your investment in RELIGARE ENT. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

RELIGARE ENT. - STC INDIA COMPARISON

COMPARE RELIGARE ENT. WITH

MARKET STATS